Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis
Leading scientists at Defence Science and Technology Laboratory have made an exciting new discovery in the fight against some of ...
Leading scientists at Defence Science and Technology Laboratory have made an exciting new discovery in the fight against some of ...
A team of researchers from Naval Medical Research Center (NMRC) are working to understand the risks associated with Burkholderia pseudomallei ...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is soliciting research ...
The Federal Select Agent Program dictates that all research entities in the United States must rigorously assess laboratory protocols to ...
Melioidosis, also called Whitmore's disease, is an infectious disease that can infect humans or animals. The disease is caused by ...
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate ...
Dr. Kevin Schully, contractor and chief science officer with Naval Medical Research Center’s (NMRC) Austere environments Consortium for Enhanced Sepsis ...
An international research team has developed a mathematical model for monitoring and controlling the spread of melioidosis in Southeast Asia. ...
Spero Therapeutics, Inc. today announced that it was awarded funding of $15.7 million, with the potential for up to an additional $28.5 ...
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
No definitive diagnostic test exists for Burkholderia, a category B agent caused by Burkholderia pseudomallei bacterium, which poses a threat ...
CUBRC’s Biological and Medical Sciences team, in collaboration with EpiVax, Inc., has received a four-year grant worth $1.87 million from ...
The U.K. Defence Science and Technology Laboratory (Dstl) has received funding of up to $6.9 million from the U.S. Defense ...
The total number of incidents involving incomplete inactivation—a process to destroy the hazardous effects of pathogens while retaining characteristics for ...
Historically, Burkholderia assay development efforts have resulted in unreliable assays due, in large part, to the small genomic sample size upon ...
The US Food and Drug Administration (FDA) has awarded "Fast Track" designation to Soligenix, Inc. for development of SGX943 (dusquetide) ...
With the Deki Reader, researchers can test for a variety of diseases, such as malaria, dengue fever, melioidosis, and plague, ...
Military program managers briefed biopharmaceutical industry and research organization representatives during a Nov. 2 Industry Day, part of an initiative ...
The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development ...